Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin R Brooks

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 2, 2017
A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosisLora L Clawson, Merit Cudkowicz, Lisa Krivickas, et al.
Brain Imaging and Behavior|May 11, 2011
A longitudinal study of motor performance and striatal [18F]fluorodopa uptake in Parkinson's diseaseCatherine L Gallagher, Sterling C Johnson, Barbara B Bendlin, et al.
The Lancet. Neurology|February 19, 2013
Controversies and priorities in amyotrophic lateral sclerosisMartin R Turner, Orla Hardiman, Michael Benatar, et al.
Nature|August 23, 2011
Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementiaHan-Xiang Deng, Wenjie Chen, Seong-Tshool Hong, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 6, 2017
Best practices protocol for the evaluation of bulbar dysfunction: summary recommendations from the NEALS bulbar subcommittee symposiumGary L Pattee, Emily K Plowman, Benjamin R Brooks, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 24, 2020
A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of <i>Reldesemtiv</i> In Patients With ALSJeremy M Shefner, Jinsy A Andrews, Angela Genge, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 2, 2017
A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosisLora L Clawson, Merit Cudkowicz, Lisa Krivickas, et al.
Brain Imaging and Behavior|May 11, 2011
A longitudinal study of motor performance and striatal [18F]fluorodopa uptake in Parkinson's diseaseCatherine L Gallagher, Sterling C Johnson, Barbara B Bendlin, et al.
The Lancet. Neurology|February 19, 2013
Controversies and priorities in amyotrophic lateral sclerosisMartin R Turner, Orla Hardiman, Michael Benatar, et al.
Nature|August 23, 2011
Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementiaHan-Xiang Deng, Wenjie Chen, Seong-Tshool Hong, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 6, 2017
Best practices protocol for the evaluation of bulbar dysfunction: summary recommendations from the NEALS bulbar subcommittee symposiumGary L Pattee, Emily K Plowman, Benjamin R Brooks, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 24, 2020
A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of <i>Reldesemtiv</i> In Patients With ALSJeremy M Shefner, Jinsy A Andrews, Angela Genge, et al.
Pageof 2